Literature DB >> 11032062

Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix.

U Wollina1, T Karamfilov.   

Abstract

Pyoderma gangrenosum sometimes takes a recalcitrant course that is unresponsive to standard immuno-suppression with corticosteroids and/or cyclosporin A. In these cases improvement of painful ulcerations is a therapeutic challenge. We report a 17-year-old boy with severe pyoderma gangrenosum treated successfully with mycophenolate mofetil and autologous keratinocyte transplantation using an esterified hyluronic acid delivery system.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11032062     DOI： 10.1046/j.1468-3083.2000.00019.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


  6 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

3.  Pyoderma Gangrenosum and Full-Thickness Burns: is there a Problem of Differential Diagnosis?

Authors:  B Napoli; N D'Arpa; F Conte
Journal:  Ann Burns Fire Disasters       Date:  2006-06-30

Review 4.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05

Review 5.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

Review 6.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.